Crohn's Disease and Colitis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- A doctor has confirmed the person has a diagnosis of Crohn's disease or ulcerative colitis.
- The person has had ongoing pain (in the abdomen or elsewhere in the body) related to their IBD for at least 3 months.
- The person scores 60 or above on a standardised pain questionnaire called the NIH PROMIS Pain Interference scale, which measures how much pain affects daily life.
- The person's condition is currently stable, meaning they have not been hospitalised due to IBD in the past 3 months, and there are no plans for IBD surgery or significant changes to their IBD treatment in the next 2 months (such as starting a new advanced medication, increasing a dose, switching treatments, or completing a steroid taper).
- The person is able to read, understand, and fill out questionnaires on their own in English.
- The person has access to a device with internet connection (such as a phone, tablet, or computer) for completing online surveys and taking part in the study program.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a cognitive impairment or another condition that the trial investigators believe would make it difficult to participate in the study.
- People who are currently taking regular opioid pain medications (such as codeine, oxycodone, or morphine used on a standing, ongoing basis).
- People who have previously taken part in cognitive behavioural therapy (a type of structured talking therapy) that was specifically aimed at managing chronic IBD-related pain.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Christopher V Almario, MD, MSHPM, Cedars-Sinai Medical Center
Phone: 310-423-0699
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
PROMIS Pain Interference
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.